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Hepatitis C virus (HCV) nonstructural protein 3 (NS3) possesses multiple enzyme activities. The N-terminal
one-third of NS3 primarily functions as a serine protease, while the remaining two-thirds of NS3 serve as a
helicase and nucleoside triphosphatase. Whether the multiple enzyme activities of NS3 are functionally
interdependent and/or modulated by other viral NS proteins remains unclear. We performed biochemical
studies to examine the functional interdependence of the NS3 protease and helicase domains and the modu-
lation of NS3 helicase by NS5B, an RNA-dependent RNA polymerase (RdRp). We found that the NS3 protease
domain of the full-length NS3 (NS3FL) enhances the NS3 helicase activity. Additionally, HCV RdRp stimulates
the NS3FL helicase activity by more than sevenfold. However, the helicase activity of the NS3 helicase domain
was unaffected by HCV RdRp. Glutathione S-transferase pull-down as well as fluorescence anisotropy results
revealed that the NS3 protease domain is required for specific NS3 and NS5B interaction. These findings
suggest that HCV RdRp regulates the functions of NS3 during HCV replication. In contrast, NS3FL does not
increase NS5B RdRp activity in vitro, which is contrary to a previously published report that the HCV NS3
enhances NS5B RdRp activity.
Hepatitis C virus (HCV) infection causes liver diseases such
as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. It
infects approximately 170 million people worldwide, and the
majority of HCV-exposed individuals become persistently in-
fected (51, 57). HCV belongs to the Hepacivirus genus of the
Flaviviridae family and is divided into six major genotypes and
numerous subtypes based on genome sequence heterogeneity
(13, 48). The viral genome is a single-stranded positive-sense
RNA that encodes a single open reading frame (7, 8). Upon
translation, the polyprotein is processed by both cellular and
viral proteases into individual structural and nonstructural
(NS) proteins (47). The structural proteins (E1, E2, C, and
probably p7) are proteolytically cleaved from the N-terminal
portion of the viral polyprotein by cellular signal peptidases
(17, 31, 52), while the NS proteins (NS2, NS3, NS4A, NS4B,
NS5A, and NS5B) are produced by the polyprotein processing
at the NS2–NS3 junction by the NS2-3 metalloprotease and at
the downstream sites of NS3 by the NS3 serine protease (1, 10,
21, 32, 33).
HCV structural proteins are required for virus entry, assem-
bly, and egression, while the NS proteins play many important
roles in viral polyprotein processing, RNA replication, and
pathogenesis (2, 3, 39, 49). A significant advance in the under-
standing of HCV replication was the establishment of sub-
genomic replicons of HCV, which can replicate in the cultured
cells (5, 34). These studies revealed that NS3, NS4A, NS4B,
NS5A, and NS5B proteins are sufficient for RNA replication.
Mutational analysis of replicable HCV RNAs further implied
that the NS3 to -5B proteins likely represent the core set of
viral proteins necessary for HCV RNA replication in vivo (12,
29, 36). These proteins colocalize with each other and with the
replicating HCV RNA predominantly in the perinuclear mem-
brane regions (12, 54). Also, subcellular fractionation studies
demonstrated that each of the NS3 to -5B proteins was local-
ized in the same membrane fraction (12, 54). These findings
suggest that the NS3 to -5B proteins form a membrane-bound
multiprotein complex where HCV RNA replicates. The inter-
action of these proteins and the effects of those interactions on
viral RNA replication remain poorly understood. It is clear,
however, that NS3 and NS5B are essential for HCV replication
in vivo (29).
NS3 is a multifunctional protein possessing protease, heli-
case, and nucleoside triphosphatase (NTPase) activities lo-
cated in two functionally distinct domains (1, 10, 16, 21, 22, 25,
26, 30, 56). The N-terminal one-third of NS3 primarily serves
as a serine protease that associates with NS4A to proteolyti-
cally process the viral polyprotein at the junctions between
NS3/4A, 4A/4B, 4B/5A, and 5A/5B (10). This region is also
required for the NS2-3 metalloprotease responsible for cleav-
age at the NS2–NS3 junction (16, 21, 59). The C-terminal
two-thirds of NS3 have helicase and NTPase activities (25, 26).
A number of biochemical studies demonstrated that the pro-
tease and helicase domains of NS3 are active when expressed
separately in vitro (25, 26, 38, 55). However, there is no evi-
dence to suggest that the protease and helicase domains of
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NS3 are proteolytically cleaved during HCV replication in the
cell. There is circumstantial evidence suggesting that the NS3
protease domain might modulate its helicase activity in vitro
(22, 23, 40). This observation, however, remains to be con-
firmed.
NS5B is the viral RNA-dependent RNA polymerase (RdRp)
responsible for catalyzing RNA polymerization during HCV
replication (4). Replication of HCV RNA takes place in the
membrane-bound replication complex (11, 12, 41, 54). Both
NS3 and NS5B are assumed to function together during HCV
RNA replication. One model is that the NS3 helicase could
unwind RNA secondary structures and/or a double-stranded
RNA (dsRNA) intermediate before RNA synthesis by NS5B
(43). NS3 was reported to interact with NS5B and with NS4A
in the cell (24). A recent report by Piccininni et al. suggested
that the HCV NS3 protein interacts with NS4B and NS5B in
far Western blot assays. Furthermore, they observed that NS3
could stimulate NS5B RdRp activity (44). Whether the HCV
RdRp modulates NS3 helicase activity has not been experi-
mentally examined.
In this study, we expressed and purified a full-length NS3
(NS3FL), a truncated NS3 helicase domain (NS3H), and NS5B
of HCV genotype 1b. The enzyme activities of these recombi-
nant proteins were directly compared in vitro. We show that
the NS3FL was about fivefold more active than NS3H in he-
licase but not NTPase activity, suggesting that the NS3 pro-
tease domain contributes to helicase activity. Additionally,
HCV RdRp (NS5B) was found to stimulate the NS3 helicase
but not NTPase activity. In contrast, NS5B failed to stimulate
the helicase of NS3H, suggesting that the NS3 protease is
required for helicase stimulation by NS5B. Glutathione
S-transferase (GST) pull-down experiments and fluorescence
spectroscopy analysis were performed to determine whether
the NS3 protease domain mediates a protein-protein interac-
tion between NS3 and NS5B. Interestingly, NS5B was found to
specifically interact with NS3FL but not NS3H. These findings
suggest a possible coordination between the HCV RdRp ac-
tivity and helicase activity through the NS3 protease domain.
In contrast, the NS3-NS5B interaction did not significantly
affect NS5B RdRp activity in vitro on HCV-specific or nonviral
RNA templates.
MATERIALS AND METHODS
DNA construction. Both cDNAs encoding NS3FL and the C-terminal 450
amino acids of the NS3 helicase domain (NS3H) of HCV genotype 1b were
amplified by PCR using pBR322/I377-NS3-3/S1179I (37) as a template and
different sets of synthetic oligonucleotide primers. 1b-His-NS3 (5-CGCGCCA
TGGCACACCACCACCACCACCACGCGCCTATTACGGCCTACTC-3)
and 1b-NS3-EcoRI (5-GGAATTCTACGTGACGACCTCCAGGTCAG-3)
were used for PCR amplification of NS3FL cDNA. The PCR DNA was cut by
restriction enzymes NcoI and EcoRI and cloned into pET21d vector (Novagen)
that was also digested with NcoI and EcoRI. The NS3H cDNA was amplified by
PCR using NS3H-BspHI (5-GCGCAAGCTTCATGAGGTCCCCGGTCTTC
ACGGAC-3) and NS3-His (5-CGCGAAGCTTCAGTGGTGGTGGTGGTG
GTGCGTGACGACCTCCAGGTCAG-3) as primers. PCR DNA was digested
with BspHI (NcoI compatible) and HindIII and inserted into the vector pET-21d
similarly cut by the same enzymes. The resulting DNA constructs were desig-
nated pET-21d-NS3FL and pET-21d-NS3H, respectively. An amino acid muta-
tion from cysteine to histidine at residue 292 (C292H) was introduced by two-
step PCR using two sets of primers. The 5-end portion of the DNA was
amplified using primers NS3-NcoI (5-CATGCCATGGCGCCTATTACGGCC
TAC-3) and C292H/3 (5-GTGGTGCTCATCACATATTATGATGC-3),
while the 3 portion was amplified with C292H/5 (5-TAATATGTGATGAGC
ACCACTCAACTGACTC-3) and NS3-His as primers and pET-21d-NS3FL as
a template. For the second-round PCR, both 5 and 3 PCR DNAs were used as
templates and NS3-NcoI and NS3-His were used as primers. The PCR DNA was
digested with NcoI and HindIII and cloned into pET21d vector between NcoI
and HindIII sites, resulting in pET21d/NS3FL-C292H. The NS5B cDNA was
also amplified by PCR using NS5B-BspHI (5-CGGGATCCTCATGAGCATG
TCCTACACATGGACAGGC-3) and NS5B21-XhoI (5-CGCGCTCGAGTC
AGTGGTGGTGGTGGTGGTGGCGGGGTCGGGCACGAGACAGGC-3)
as primers and pBR322/I377-NS3-3/S1179I as a template. PCR DNA was di-
gested with BspHI (compatible with NcoI site) and XhoI and inserted into
pET21d vector between the NcoI and XhoI sites. A His6 tag was added to either
the N or C termini of NS3 and NS5B proteins to facilitate protein purification.
To express a GST-NS5B fusion protein, the cDNA of NS5B of genotype 1b
was amplified by PCR using pBR322/I377-NS3-3/S1179I as a template and
NS5B-BspHI and NS5B21-XhoI as primers. The NS5B PCR product was
digested by BamHI and XhoI and inserted into a pGEX-4T-1 vector (Amersham
Pharmacia Biotech), which was similarly digested with BamHI and XhoI, result-
ing in a construct designated pGEX-4T/NS5B.
The West Nile virus (WNV) RdRp (amino acids 266 to 905) cDNA was PCR
amplified from an infectious cDNA clone of a New York strain of WNV (53) and
cloned into the expression vector pET-28a (Novagen) between the restriction
enzyme sites NdeI and XhoI, resulting in a construct designated pET-28a-WNV-
RdRp. The WNV RdRp expressed from pET-28a-WN-RdRp contained a His6
tag at the N terminus.
Protein expression and purification. NS3FL, NS3H, HCV NS5B21, and
WNV RdRp were expressed in Escherichia coli strain BL21 (Novagen). The
cultures were grown in LB medium at 37°C until the optical density at 600 nm
(OD600) reached 1.0 and induced by addition of isopropyl--D-thiogalactopyr-
anoside (IPTG) to 1 mM. After an additional incubation at 18°C for 20 h, cells
were harvested by centrifugation at 6,000  g for 10 min and resuspended in a
lysis buffer containing 50 mM Na3PO4, pH 8.0, 300 mM NaCl, 5 mM 2-mercap-
toethanol, 10% glycerol, 0.5% Igepal CA630, and a protease inhibitor cocktail
consisting of 1 mM phenylmethylsulfonyl fluoride, 0.5 g/ml leupeptin, pepstatin
A, and 2 mM benzamidine. Cells were lysed by freezing and thawing, followed by
sonication. Cell debris was removed by centrifugation at 12,000  g for 30 min.
The supernatant was further clarified by passing though a 0.45-m filter (Corn-
ing) and then loaded onto a HiTrap chelating column charged with NiSO4
(Amersham Pharmacia Biotech). The bound protein was eluted with an imida-
zole solution in a 100-to-500 mM linear gradient. Selected fractions through Ni2
column chromatography were analyzed on a 10% sodium dodecyl sulfate (SDS)-
polyacrylamide gel. Protein concentrations were determined by spectrophotom-
etry using the calculated extinction coefficients for each protein. For expression
of a GST-NS5B fusion protein, E. coli strain BL21pLysS(DE3) transformed with
pGEX-4T/NS5B was grown at 37°C in LB medium containing 100 g/ml of
ampicillin to an OD600 of 0.6. The protein expression was induced by addition of
0.4 mM IPTG at 25°C for 8 h. Bacteria were harvested, pelleted down, and
resuspended in phosphate-buffered saline (PBS) buffer, containing 1% Triton
X-100, and protease inhibitor cocktail described above. Lysates clarified as de-
scribed above were loaded onto a GSTrap HP column (Amersham Pharmacia
Biotech). The column was washed with PBS buffer. The bound GST-NS5B fusion
protein was eluted with an elution buffer (50 mM Tris-HCl and 10 mM reduced
glutathione; pH 8.0). The pooled GST fusion protein fractions were concen-
trated by polyethylene glycol 8000 and then loaded onto a fast performance
liquid chromatography (FPLC) Superdex-200 gel filtration column that was
equilibrated in FPLC buffer (50 mM Tris-HCl, pH 7.5, 10% glycerol, and 5%
-mercaptoethanol containing 150 mM KCl). The GST fusion protein was con-
firmed by Western blot analysis. The purity of the isolated proteins was examined
by electrophoresis on a 10% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) gel and stained with Coomassie blue. The control GST protein was also
expressed and purified using the same protocol. The purified proteins were
divided into aliquots and stored at 80°C.
The WNV RdRp was expressed in E. coli BL21 in LB medium at 30°C to an
OD600 of about 0.8 and induced by addition of 1 mM IPTG at 30°C for 4 h.
Otherwise, the purification scheme was the same as for HCV NS5B.
Western blot analysis. Purified NS3H, NS3FL, and NS5B21 proteins were
resolved by electrophoresis in a 12% SDS-PAGE gel and then transferred onto
a nitrocellulose membrane. The HCV proteins were determined by Western blot
analysis using monoclonal antibodies against NS3 and NS5B proteins. Proteins
were visualized by using a chemiluminescence kit (Roche) with horseradish
peroxidase-conjugated goat anti-mouse antibodies (Pierce) as secondary anti-
bodies.
Preparation of NS3 helicase substrate. A short dsDNA was formed by hybrid-
ization of two synthetic oligonucleotides, a 30-nucleotide (nt) releasing strand










(5-TGGTACTCCTCACACCTGGGCGGCGGTTAA-3) and a 54-nt DNA
(5-GACTACGTACTGTTAACCGCCGCCCAGGTGTGAGGAGTACCAG
GCCAGATCTGC-3). The 30 nt were labeled with 32P at the 5 end by use of
[-32P]ATP (MP Biomedicals) and T4 polynucleotide kinase (New England
Biolabs) at 37°C for 1 h. Unincorporated [-32P]ATP was removed by passing
through a Sephadex G-50 column (Roche). The radiolabeled 30-nt DNA was
used to anneal to an equal molar amount of longer-strand DNA (54 nt) to form
a partial dsDNA. NS3 helicase substrate has a 12-nt overhang at both the 5 and
3 ends of the longer-strand DNA.
Helicase assay. The NS3 helicase was assayed in a 10-l reaction mixture
containing 20 mM HEPES, pH 7.5, 2 mM dithiothreitol, 100 g/ml bovine serum
albumin, 3 mM MgCl2, various amounts of enzyme and substrate as indicated,
and 0.5 pmol of a 30-nt capture oligonucleotide (5-TTAACCGCCGCCCAGG
TGTGAGGAGTACCA-3). The reaction was initiated by addition of 5 mM
ATP and incubated at 37°C for 30 min and then stopped by addition of a glycerol
loading buffer containing 20 mM EDTA and 0.5% SDS. The products were
analyzed in a 12% native polyacrylamide gel and quantitated with a Phospho-
rImager (Molecular Dynamics). The unwound products were calculated as the
percentage of the total DNA substrate. A synthetic NS4A core peptide (KK-G
SVVIVGRIILSGRPAIVP-KK) was used for its effect on the NS3FL helicase
activity. To determine the effects of NS5B on NS3 helicase activity, increasing
amounts of NS5B were added into the helicase reaction mixture. As controls,
increasing amounts of WNV RdRp or HCV NS5B21 itself were incubated with
a partially duplex DNA substrate under the same reaction conditions as above.
NTPase assay. The protocol of Cui et al. was used to assay NTPase activity (9).
Briefly, the 10-l reaction mixture contained 20 mM HEPES, 3 mM MgCl2, 2
mM dithiothreitol, 100 g/ml bovine serum albumin, 0.5 mM cold ATP spiked
with 1 Ci [-32P]ATP (4,500 Ci/mmol; MP Biomedicals), and NS3FL or NS3H
at the indicated concentrations. The reaction mixture was incubated at 37°C for
30 min and then stopped by the addition of EDTA to 50 mM. One-tenth of the
reaction mixture was spotted onto a thin-layer chromatography plate coated with
polyethyleneimine cellulose (J.T. Baker). The radioactive phosphate hydrolyzed
from [-32P]ATP was separated by chromatography using 0.375 M potassium
phosphate (pH 3.5) as a running buffer. The hydrolyzed phosphate was quanti-
fied with a PhosphorImager (Molecular Dynamics).
GST pull-down assay. GST protein (2 g) or a GST-NS5B fusion protein (2
g) was incubated with 20 l of a 50% slurry of glutathione-agarose gel at 4°C
for 2 h with rotation. After washing with PBST buffer (phosphate-buffered saline
containing 1% Triton X-100), GST-bound resins were incubated with 2 g of
His-tagged NS3 protein in 300 l of PBS buffer containing 0.5% Igepal CA630
at 4°C for 2 h and then washed with NETN 300 buffer (20 mM Tris-HCl, pH 7.4,
0.1 mM EDTA, and 300 mM NaCl). Proteins bound to the glutathione-agarose
gel (Pierce) were resuspended in a loading buffer, denatured, and loaded into a
10% SDS-PAGE gel. Proteins were subsequently transferred onto a membrane,
followed by Western blot analysis using an anti-NS3H monoclonal antibody.
Analysis of NS3FL-NS5B interaction using fluorescence spectroscopy. Fluo-
rescence measurements were made at room temperature (22 to 23°C) with a
Perkin-Elmer luminescence spectrometer LS55 and cuvettes with an optical path
length of 0.4 cm. Equilibrium anisotropy measurements were performed with a
version of the HCV NS5B21 protein which was engineered to have a tetracys-
teine motif capable of binding to the FlAsH dye (Y. C. Kim, unpublished data).
When dialyzed with the FlAsH dye, approximately 15% of the protein will
incorporate a dye molecule. After removal of the free dye, NS5B21 at 0.2 M
was titrated with increasing concentrations of NS3FL in buffer A (50 mM
HEPES, pH 7.5, 50 mM NaCl, 5 mM MgCl2, and 0.002% Tween 20). Measure-
ments were taken with an integration time of 1 second and a slit width of 5 nm
of both excitation (500 nm) and emission (530 nm). Anisotropy values were
recorded after 20 s after each addition of NS3FL to allow the sample to reach
equilibrium. Anisotropy measurements were repeated 10 times for each sample,
and the resulting values were averaged.
Binding data were analyzed by nonlinear least square fitting using Kaleida-
Graph software (Synergy Software, Reading, PA). The Hill equation was used to
determine the Kd as follows: A 	 Bmax xn/(xn  Kdn) (Hill equation). In this
equation, A is the value of anisotropy change by the ligand binding, Bmax is the
value of maximum anisotropy change, x is the total concentration of the input
NS3FL, and the exponential term (n) is the Hill coefficient, which can be used to
estimate the extent cooperative binding.
RdRp activity assays. Standard RdRp assays consisted of 0.125 M of tem-
plate RNA with 0.08 M of NS5B in a 20-l reaction mixture containing 20 mM
sodium glutamate (pH 8.2), 4 mM MgCl2, 12.5 mM dithiothreitol, 0.5% (vol/vol)
Triton X-100. Reactions with LE21 as template had 200 M GTP, 100 M ATP
and UTP, and 250 nM [
-32P]CTP (Amersham Inc.). Where indicated, NS3FL
and NS3H were at 1 (1:1) and 2 (1:2) that of NS5B. Assays were performed
with both NS5B21 and full-length NS5B (NS5BFL). The assay using template
H121 was performed only with NS5B21 at 1:1 and 1:2 molar ratios of NS5B to
NS3. One part of the reaction was performed with 200 M GTP, 100 M ATP
and UTP, and 500 nM [
-32P]CTP, and the other was with 200 M GTP, 100 M
ATP and CTP, and 500 nM [
-32P]UTP. In all cases, the reaction mixture was
adjusted for the final buffer content. RNA synthesis reaction mixtures were
incubated at 25°C for 60 min and stopped by phenol-chloroform extraction
followed by ethanol precipitation in the presence of 5 g of glycogen and 0.5 M
ammonium acetate. Products were separated by electrophoresis on denaturing
(7.5 M urea) polyacrylamide gels. Gels were wrapped in plastic and exposed to
film at 80°C.
RESULTS
Protein expression and purification. The goal of this study
was to analyze the possible contributions of both the NS3
helicase and protease domains to known activities and for
possible interactions between NS3 and NS5B. All of the pro-
teins, NS3FL, NS3H, NS5B21, NS5BFL, and the WNV
RdRp, were expressed in E. coli and purified through Ni2
column chromatography to greater than 95% purity in Coo-
massie blue-stained denaturing protein gels (Fig. 1A and data
not shown). Additionally, the identities of the NS3 and NS5B
proteins were confirmed by Western blot analysis using NS3-
and NS5B-specific antibodies (Fig. 1B).
Comparison of enzyme activities of purified recombinant
NS3FL and NS3H. It has been previously demonstrated that
HCV NS3 is able to unwind partially duplex nucleic acids
(RNA-RNA, RNA-DNA, or DNA-DNA) without exhibiting
substrate specificity in vitro (19, 20, 30). Also, NS3 helicase
requires a 3-end single-stranded overhang in order for initia-
tion of duplex unwinding in the 3-to-5 direction (19). There-
fore, a partial dsDNA substrate was prepared by annealing a
30-nt synthetic DNA to a 54-nt DNA, resulting in a 12-nt
single-stranded DNA overhang at both the 5 and 3 ends (Fig.
2A). A 30-nt capture oligonucleotide, which is fully comple-
mentary to the radiolabeled short DNA strand, was added in
fivefold excess to the helicase reaction mixture in order to stop
the reannealing of the released strand back to the longer DNA
strand. The newly formed dsDNA between the capture DNA
and the released strand was fully complementary and should
not serve as a substrate for NS3 helicase (Fig. 2A). This assay
was initially validated by NS3FL. As shown in Fig. 2B, NS3FL
helicase activity efficiently unwound the partially duplexed
DNA in a dose-dependent manner (Fig. 2B and C). The sub-
strate unwinding was linearly correlated with increasing
amounts of enzyme up to 0.4 pmol and reached a maximum at
0.8 pmol protein (Fig. 2C). In contrast, NS3FL/C292H, which
contains a cysteine-to-histidine mutation at amino acid 292 in
the conserved helicase DCEH motif (30), failed to unwind
dsDNA (Fig. 2B and C). These results demonstrate that the
substrate unwinding by NS3FL was the activity of the HCV
NS3 protein. In addition, we examined the protease activity of
purified NS3FL using an in vitro-translated NS5A-NS5B pro-
tein as substrate. NS3FL was able to efficiently cleave an
NS5A-NS5B precursor into NS5A and NS5B proteins (data
not shown). Taken together, these findings demonstrate that
purified NS3FL contains both functional protease and helicase
activities.
Circumstantial evidence derived from previous studies sug-
gests that the protease and helicase/NTPase domains of the
NS3 are functionally interdependent (23, 40, 42). To further










determine the effect of the protease domain on the enzyme
activities of the helicase domain, we directly compared the
helicase and NTPase activities between NS3FL and NS3H. As
shown in Fig. 3, NS3FL unwound the substrate more efficiently
than NS3H. The substrate unwinding was proportional to in-
creasing amounts of NS3FL up to 0.8 pmol protein, at which it
reached a maximum unwinding at 85% of total substrate. How-
ever, NS3H unwound the duplex DNA substrate less efficiently
and did not reach the plateau until at least 3.2 pmol of protein
was used (Fig. 3A). Since fivefold more NS3H than NS3FL was
required to achieve a similar substrate unwinding, the presence
of the NS3 protease domain significantly enhances the NS3
helicase activity. This finding was confirmed by using a previ-
ously described RNA substrate (14). Similar to unwinding of
dsDNA substrate, NS3FL unwound the partially duplex RNA
more efficiently than NS3H (data not shown). These results are
consistent with previous findings that HCV NS3 helicase does
not discriminate DNA and RNA substrates in vitro (19, 20,
30). Additionally, a synthetic NS4A core peptide (KK-GSVV
IVGRIILSGRPAIVP-KK) (58) was found to stimulate the
NS3FL helicase by up to fourfold at a 100 M concentration
(data not shown). In contrast, there was no significant differ-
ence in their NTPase activities when NS3FL and NS3H were
compared in parallel (Fig. 3B). We also examined the NTPase
activities of NS3FL and NS3H in the presence of dsDNA
substrate and did not observe any significant difference in
NTPase activity (data not shown). These findings indicate that
the enhancement of the NS3 helicase by the protease domain
was not due to NTPase activation and that both proteins were
properly folded for NTPase activity. This is consistent with a
previous observation that the NS3 NTPase is uncoupled with
its helicase translocation (43). Thus, the NS3 protease domain
specifically up-regulates the NS3 helicase activity.
Specific stimulation of NS3 helicase by HCV RdRp. Both
NS3 helicase and NS5B RdRp are required for HCV RNA
replication (29). It was previously reported that NS3 colocal-
ized with NS5B in the cell (24). Whether the NS3 helicase
activity is modulated by direct interaction between NS5B and
NS3 has not been experimentally examined. Therefore, we
determined whether NS5B affects the NS3 helicase activity in
vitro. We first determined whether the unwinding efficiency
changed over time. When a 5:1 ratio of the enzyme and sub-
strate was used, the NS3FL helicase efficiently unwound the
DNA substrate with a maximum unwinding efficiency reached
within 30 min. More than 50% of substrate was actually un-
wound within 5 min (Fig. 4). When the enzyme and substrate
ratio was reduced to 1:1 (0.1 pmol enzyme and substrate), the
substrate unwinding efficiency was much less, with release of
only about 10% of substrate even after 60-minute incubation
(Fig. 4). A suboptimal substrate unwinding efficiency would be
more likely to reveal whether NS5B stimulates the NS3FL
helicase activity. Accordingly, the helicase activity of NS3FL
was examined in the presence of increasing amounts of
NS5B21 protein. As shown in Fig. 5, the efficiency of sub-
strate unwinding was proportionally correlated with increasing
concentrations of NS5B21. Based on the substrate unwinding
efficiency, it was estimated that NS5B21 stimulated the NS3
helicase by seven- to eightfold (Fig. 5 and 6). As a control,
NS5B itself did not display any helicase activity (Fig. 5). To
rule out the possibility that NS5B might stimulate the NTPase
activity, since the helicase is coupled with ATP hydrolysis, we
examined the effect of NS5B on the NS3FL NTPase activity.
Results from this experiment did not show any effect of NS5B
on the NS3FL NTPase (data not shown). To further determine
the specificity of the NS3 helicase stimulation by HCV RdRp,
the RdRp from West Nile virus, also a flavivirus, was used in
the NS3FL helicase assay and found to not exhibit any stimu-
latory activity at all on the HCV NS3 helicase. Taken together,
these findings clearly demonstrate that HCV RdRp specifically
stimulated the NS3FL helicase but not NTPase activity in vitro,
suggesting a cooperative up-regulation of the NS3 helicase by
RdRp during HCV RNA replication.
Requirement of the NS3 protease domain for helicase stim-
ulation by NS5B. To determine whether the NS3FL helicase
stimulation by RdRp requires the NS3 protease domain, NS3H
was used in the helicase assay. Since the NS3H was about
FIG. 1. (A) Electrophoresis analysis of purified recombinant NS3
and NS5B proteins. Protein expression and purification are described
in Materials and Methods. Two hundred nanograms of each protein
was loaded onto a 12% polyacrylamide–SDS gel. Protein bands were
visualized by Coomassie blue staining. The name of the protein is
shown on the top, and the sizes of protein molecular mass markers are
indicated on the left. (B) Confirmation of NS3 and NS5B proteins by
Western blot analysis. NS3H, NS3FL, and NS5B were separated as for
panel A and then transferred onto a nitrocellulose membrane. Mono-
clonal antibodies specific to NS3 and NS5B were used for Western blot
analysis.










fivefold lower in helicase activity than NS3FL, an approxi-
mately equivalent substrate unwinding activity of NS3H to
NS3FL was used in the helicase assay. Contrary to NS3FL, the
NS3H helicase activity was not significantly affected by the
addition of increasing amounts of NS5B21 (Fig. 6). These
results demonstrate that the NS3 protease domain was re-
quired for helicase stimulation by NS5B. This finding also
suggests that the NS3 protease domain might mediate a spe-
cific protein-protein interaction between NS3FL and NS5B.
NS3-NS5B interaction revealed by GST pull-down. To de-
termine a protein-protein interaction between NS3 and NS5B,
a GST pull-down experiment was performed. NB5B bound to
glutathione-agarose was incubated with either NS3FL or
NS3H protein. GST protein alone was used as a control in this
experiment. Coprecipitated proteins were detected by Western
blot analysis using a monoclonal antibody against the NS3
helicase domain. As shown in Fig. 7, NS5B specifically pulled
down the NS3FL but not NS3H (Fig. 7), suggesting that the
protease domain was required for NS3 and NS5B interaction.
GST did not pull down any NS3 protein, demonstrating that
the NS3 protease mediated a specific NS3-NS5B interaction.
Determination of NS5B and NS3FL interaction by fluores-
cence spectroscopy. To more quantitatively analyze the inter-
action between NS5B and NS3FL, we used a recombinant
NS5B21 molecule that has been engineered to bind the
FlAsH dye (18). This protein is fully capable of de novo initi-
ating RNA synthesis and does not appear to be significantly
affected in any of the known activities (Y. C. Kim, unpublished
FIG. 2. (A) Schematic of the helicase assay. A synthetic 30-nt oligonucleotide was annealed to a 54-nt DNA to form a partially duplex DNA
substrate. Upon duplex unwinding by NS3 helicase, the 5-end 32P-radiolabeled release strand (indicated by P* at the 5 end) is trapped by a
complementary capture oligonucleotide. (B) Titration of the NS3FL helicase. A 0.1-pmol aliquot of dsDNA substrate was incubated with
increasing amounts of NS3FL or an inactive helicase mutant, NS3FL/C292H, at 37°C for 30 min. The unwound substrate products were analyzed
in a native 12% polyacrylamide gel. The percentage of substrate unwound, indicated at the bottom, was determined by from the quantitative data
derived from phosphorimager results. Amounts of NS3FL used are indicated on the top. (C) Correlation of NS3FL helicase activity with enzyme
concentrations. The quantitative data are derived from panel B.
FIG. 3. (A) Comparison of helicase activities of NS3FL and NS3H. The helicase assay was the same as that in Fig. 2. (B) Comparison of the
NTPase activities of NS3FL and NS3H. The NTPase activity is expressed as the percentage of radioactive phosphate converted from [-32P]ATP.
The enzyme concentrations (x axis) are plotted against the percentage of conversion of phosphate from ATP (y axis). E, NS3FL; Œ, NS3H.










data). However, having a dye-labeled version of NS5B21 al-
lowed us to examine the properties of the protein even in the
presence of other molecules that could otherwise affect the
spectroscopic properties of the solution. In the presence of
increasing NS3FL, we observed a significant change in the
anisotropy of NS5B21 that started to saturate when NS3FL
protein reached about 5 M (Fig. 8). The binding isotherm was
used to derive the affinity of the NS5B-NS3FL interaction, with
a Kd of approximately 2 M. In contrast, the Kd for interaction
between NS5B21 and NS3H was higher than 50 M (Fig. 8).
Therefore, these results from fluorescence anisotropy are in
agreement with those from the GST pull-down assays (Fig. 7),
demonstrating that the NS3 protease domain is required for a
tighter interaction with NS5B.
Effect of NS3 on RdRp activity of NS5B. In order to examine
whether the HCV NS3 could affect RNA synthesis by the HCV
RNA polymerase in vitro, we used two previously character-
ized RNA templates that are both capable of directing de novo
initiation (Fig. 9A) (45, 46). A short 21-nt RNA named LE21
can form a quasi-stable intramolecular hairpin with a single-
stranded 3 sequence that is capable of directing de novo
initiation of RNA synthesis. When the polymerase reaches the
FIG. 4. (A) Time course of NS3FL helicase activity. A 0.1-pmol aliquot of dsDNA substrate was incubated with either 0.1 pmol or 0.5 pmol
NS3FL enzyme (as indicated at the bottom) at 37°C. At different time points (indicated on the top), the reactions were stopped by addition of a
loading buffer containing 20 mM EDTA and 0.5% SDS. The unwound products were analyzed in a 12% native polyacrylamide gel, visualized by
autoradiograph, and quantified by use of a phosphorimager. (B) Relation of NS3FL helicase activity to incubation time. The quantitative data from
panel A were used to plot the incubation time (x axis, in min) against the percentage of unwound substrate (y axis). F, 0.1 pmol NS3FL; Œ, 0.5
pmol NS3FL.
FIG. 5. Stimulation of NS3FL helicase activity by HCV RdRp. A
partially duplex DNA substrate was incubated with 0.1 pmol NS3FL
and increasing amounts of NS5B21 at 37°C for 30 min (left panel). As
controls, the helicase substrate was incubated with increasing amounts
of NS5B in the absence of NS3FL (right panel). The unwound sub-
strate products were resolved in a 12% native polyacrylamide gel,
visualized by autoradiograph, and quantified with a phosphorimager.
The percentage of unwound substrate is shown at the bottom, and the
amounts of NS5B are indicated on the top.
FIG. 6. Specificity of NS3 helicase stimulation by HCV RdRp. A
viral RdRp derived from WNV was used as a nonspecific control to
compare with HCV RdRp in stimulation of the NS3FL helicase. The
dsDNA substrate was incubated with 0.1 pmol NS3FL or 0.5 pmol
NS3H and increasing amounts of either HCV NS5B or WNV NS5 at
37°C for 30 min. A 0.5-pmol aliquot of NS3H was used here, which
achieved an unwinding efficiency approximately equivalent to 0.1 pmol
NS3FL, since the helicase activity of NS3H is about fivefold lower than
that of NS3FL. The unwound products were separated by electro-
phoresis in a 12% native polyacrylamide gel, visualized by autoradio-
graph, and quantified with a phosphorimager., 0.1 pmol NS3FL plus
NS5B; Œ, 0.5 pmol NS3H plus NS5B; E, 0.1 pmol NS3FL plus WNV
NS5.










5 end of LE21, it could either terminate RNA synthesis, thus
producing a 21-nt de novo-initiated RNA, or use a second
template to generate a recombinant RNA product of 42 nt. In
addition, two molecules of LE21 can partially anneal to direct
primer-dependent RNA synthesis, generating a 34-nt product.
The addition of either NS3H or NS3FL did not significantly
alter the type or the amount of products synthesized by
NS5B21. To ensure that the lack of the C-terminal 21 amino
acids did not prevent a possible effect of NS3, we also tested a
full-length NS5B protein. Again, no significant effect on RNA
synthesis was observed in the presence of NS3H or NS3FL. In
some experiments, we did observe a 20 to 30% decrease in the
amount of products made from LE21 in the presence of
NS3FL (R. Kumar, unpublished data).
The lack of an effect on RNA synthesis from LE21 could be
because it lacks a sufficiently structured region that would
require the function of an RNA helicase. To examine this
possibility, we used the 121-nt RNA derived from the 3 end of
the HCV minus-strand RNA genomes as a template. Unex-
pectedly, we found that the addition of NS3FL or NS3H at
higher concentrations inhibited RNA synthesis by NS5B21 in
our standard reaction. One possible reason for this is that the
ATPase activity of NS3 could decrease the concentration of
the already low concentration of radiolabeled nucleotide (0.3
M final concentration) and that the longer length of H121
exacerbated the inhibitory effect in comparison to product
synthesis from LE21. We have also tested RNA syntheses
using [
-32P]CTP and [
-32P]UTP as radiolabels and observed
that NS3H or NS3FL also inhibited RNA synthesis from H121.
One alternative interpretation for the inhibition of RNA syn-
thesis is that the NS3 competes with NS5B for RNA template,
since NS3 possesses an RNA-binding activity.
DISCUSSION
A consensus has not been reached as to whether the two
distinctive NS3 enzymes are functionally interdependent be-
tween the protease and helicase domains. A number of studies
have demonstrated that both the full-length NS3 and the trun-
cated protease domain alone have comparable protease activ-
ities in vitro, suggesting that the NS3 protease does not depend
on the presence of the NS3 helicase domain (14, 15, 22, 50, 55).
We have evidence from this study to show that both NS3FL
and NS3H have comparable NTPase activities. Therefore,
some activities of NS3 can be functionally independent. How-
ever, contradicting evidence exists to either support or oppose
a role of the NS3 protease domain in the modulation of its
helicase activity (14, 15, 23, 40, 42). Several studies have re-
vealed that the NS3 helicase activity is significantly enhanced
FIG. 7. Determination of NS3FL-NS5B interaction by GST pull-
down. A GST-NS5B fusion protein or GST alone (as a control) was
first incubated with glutathione-agarose gel. After washing, the GST or
GST-NS5B-bound gel was subsequently incubated with NS3FL or
NS3H, respectively. The NS3 proteins pulled down by NS5B were then
determined by Western blot analysis using a monoclonal anti-NS3H
antibody. Purified recombinant NS3FL and NS3H were used as posi-
tive controls for Western blot analysis. The sizes of protein molecular
mass markers are indicated on the left.
FIG. 8. Analysis of NS5B-NS3 interaction using fluorescence anisotropy. (A) A comparison of the interaction of between fluorescent-labeled
NS5B and either NS3H or NS3FL. Each change in anisotropy value represents the mean and one deviation from 10 measurements. (B) Fluo-
rescence anisotropy experiment to determine the affinity of the NS5B-NS3FL interaction. NS5B bound to the fluorescent dye FlAsH was
determined in the presence of increasing concentrations of NS3FL. Each data point represents the average of 10 independent measurements. The
Kd for the interaction was derived from the binding isotherm using the Hill equation, as described in Materials and Methods.










by the presence of the NS3 protease domain, as determined by
a direct comparison of the helicase activities between NS3FL
and NS3H (23, 40, 42). Consistent with this finding, NS4A was
found to further increase the helicase activity of NS3FL by
forming a noncovalent complex with the protease (23). How-
ever, these findings were not reproduced by other studies,
which did not reveal a significant difference in the helicase/
NTPase activities between full-length NS3 and the C-terminal
helicase domain (14, 15). Conversely, NS4A was reported to
inhibit rather than promote the NS3 helicase activity (15). In
contrast, findings from our studies herein clearly demonstrate
that the presence of the NS3 protease domain substantially
increased the NS3 helicase activity. At least fivefold higher
helicase activity was observed for the NS3FL than NS3H (Fig.
3). The lower helicase activity associated with the NS3H could
not be explained by any significant difference in protein folding
of the helicase in the absence of the protease domain. Previous
crystallographic studies have determined that the X-ray struc-
ture of the helicase domain itself is similar to the one found in
the full-length NS3 (6, 27, 61, 62), suggesting that the helicase
domain itself, when expressed separately, was properly folded.
Further support to this interpretation comes from the findings
that the NTPase activity of the helicase domain (NS3H) was
linearly correlated with enzyme concentrations and was com-
parable to that of the NS3FL (Fig. 3), indicating that the
helicase was correctly folded. Furthermore, the helicase activ-
ity of NS3FL was enhanced by the addition of an increasing
concentration of a synthetic NS4A core peptide (data not
shown). Taken together, these findings demonstrate that the
NS3 protease domain does up-regulate the NS3 helicase activ-
ity. This conclusion is supported by findings derived from sev-
eral other studies (22, 23, 40, 42). However, Gallinari et al. did
not observe a significant difference in helicase activity between
NS3FL and NS3H (14, 15). The reason for the discrepancy
between our results and those of Gallinari et al. is not clear (14,
15).
How the NS3 helicase activity is activated by the presence of
its protease domain has not been fully illustrated. Although the
NS3 helicase activity is coupled with its NTPase activity (30),
our findings demonstrate that the enhancement of the NS3
FIG. 9. Examination of the effects of NS3H or NS3-FL on polymerase activity of NS5B. (A) RNA templates used in the NS5B polymerase
assay. LE21 was previously characterized by Ranjith-Kumar et al. (45). H121 was derived from the 3-terminal 121 nt of the HCV minus-strand
RNA, and its ability to direct RNA synthesis was characterized by Ranjith-Kumar et al. (46). (B) Gel image of RNAs synthesized by either
NS5B21 or full-length NS5B in the absence of NS3 (denoted with ). The identities of the proteins added to the reaction mixtures are indicated
above the lanes, and the ratios indicate the stoichiometric amounts of NS5B and the appropriate NS3 protein. The sizes of the RNA products are
indicated to the right of the gel image. The 21-nt RNA was initiated de novo, the 34-nt RNA is the product of primer extension, and the 42-nt
RNA is the result of RNA synthesis from two noncovalently linked templates (45). (C) RNA synthesis by HCV NS5B21 using H121 as template.
The identities of the proteins added to the reaction mixtures and their ratios relative to NS5B21 are shown above the lanes in the gel. Because
NS3 could hydrolyze purine triphosphates, [
-32P]CTP and [
-32P]UTP were used as the radiolabeled nucleotides in the reactions shown in the
gel images to the right and left, respectively.










helicase by the protease domain was not due to activation of
the NTPase activity. NS3FL was found to exhibit a substan-
tially higher helicase activity than NS3H, but it did not affect
the level of its NTPase activity (Fig. 3). These findings suggest
that the protease domain can directly activate the helicase
without an effect on the NTPase activity. Consistent with an
earlier observation that NS4A was able to enhance functional
NS3-RNA complex formation (42), an NS4A core peptide was
also found to significantly enhance the NS3 helicase activity
(data not shown). NS4A is known to bind tightly to the pro-
tease domain of NS3 and to stabilize the NS3 structure (28, 35,
60), which is required for protease activity. Likewise, stabiliza-
tion of NS3 by NS4A may also convert NS3 into a more active
helicase. The molecular basis underlying the helicase enhance-
ment by the protease domain is probably best explained by the
atomic structure of the full-length NS3 (62). The protease and
helicase domains are segregated and covalently connected by a
short strand. A number of amino acid residues of each domain
are involved in the surface interaction at the domain interface.
Additionally, there are extensive hydrogen bond interactions
between the region containing the protease active site and the
C-terminal six residues of the helicase domain (62). These
interactions probably stabilize the enzyme in a conformation
optimal for helicase activity. Furthermore, the nucleic acid-
binding sites on the protease surface may also contribute to the
enhancement of the helicase activity by binding to the helicase
substrate (62). Mutagenesis analysis to alter interactions be-
tween the NS3 protease and helicase domains will likely pro-
vide insights into the understanding of the structural basis for
the functional dependence of the NS3 helicase on the protease
domain.
In addition to the NS3 protease, HCV RdRp (NS5B) was
found to strikingly stimulate the NS3 helicase activity by a
specific protein-protein interaction with the NS3 protease do-
main (Fig. 7 and 8). This novel finding is strongly supported by
several lines of evidence described in this report. First, NS5B
stimulation of NS3FL helicase activity occurs in a dose-depen-
dent manner (Fig. 5 and 6). In contrast, a nonspecific control
RdRp derived from WNV had no effect on the HCV NS3
helicase activity (Fig. 6). Additionally, stimulation of the NS3
helicase by NS5B is strictly dependent on the presence of the
protease domain, since NS5B failed to stimulate the helicase
activity of the NS3H that did not contain the protease domain
(Fig. 6). Similar to the NS3 protease domain, NS5B did not
affect the NTPase activity of NS3FL (data not shown). Fur-
thermore, it appeared that NS5B could inhibit the NS3 pro-
tease activity when an in vitro-translated NS5A-NS5B sub-
strate was used in a protease assay (Z. Cai et al., unpublished
result). These findings suggest that the protease domain is
required for mediating the NS3-NS5B interaction. Such a pro-
tein-protein interaction was indeed confirmed by both GST
pull-down assay and fluorescence spectroscopy analysis. NS5B
was able to specifically pull down NS3FL but not the NS3H
protein (Fig. 7). Likewise, fluorescence anisotropy analysis
demonstrated that NS5B tightly interacted with NS3FL but not
NS3H (Fig. 8). A specific interaction between NS5B and the
NS3 protease domain appears to be a prerequisite for NS3
helicase stimulation by HCV RdRp. It is noteworthy that our
results are contrary to a previous finding that NS5B could
interact with the NS3 helicase domain alone, as shown by a
membrane-binding assay (44). One possible explanation is that
the difference may be attributed to a difference in the affinity of
the NS5B interaction between NS3H and NS3FL.
It is not clear yet how NS5B interacts with the NS3 protease
domain and how such an interaction subsequently activates the
NS3 helicase activity. Understanding of these fundamental
questions will inevitably help to illustrate the molecular mech-
anism of HCV RNA replication. As discussed above, the C
terminus of NS3 forms hydrogen bond interactions with the
protease domain near the enzyme active site after cis-cleavage
by the NS3 protease (62). The N-terminal portion of NS5B
may interact with the protease domain through the protease
active site in a manner similar to the C-terminal portion of
NS3, as revealed by the structure of a single-chain NS3-NS4A
molecule (62). The NS5B N terminus is the P-side product of
the cleavage by the NS3 serine protease at the NS5A and NS5B
junction. There could be other regions involved in the inter-
action between these two molecules. Upon interaction with the
protease domain, NS5B may cause a conformational rear-
rangement of the NS3 helicase, which could increase substrate
unwinding.
Replication of most positive-strand RNA viruses takes place
in the membrane-bound replication complex consisting of viral
RNA, most NS proteins, and cellular proteins as well. The viral
replicase proteins were found to interact with each other in the
intracellular sites where viral RNA is replicated (11, 12, 41,
54). Therefore, it is conceivable that the replicase proteins
affect/regulate each other’s properties through protein-protein
interactions. The HCV NS3 represents the first viral RNA
helicase whose function is stimulated by a viral RNA polymer-
ase. Our findings also provide an explanation for the existence
of two apparently functionally independent distinct activities
(protease and helicase/NTPase) within one NS3 molecule. The
NS3 protease domain functions not only as an enzyme but also
as a mediator for a specific interaction with NS5B, which en-
hances the NS3 helicase activity.
As to the role of NS3 in RNA synthesis in vitro, our results
contrast with those previously reported by Piccininni et al., who
observed an unexpected multimeric product made from the
input template in the presence of NS3FL (44). This difference
is especially notable because both studies used a template
derived from the 3 end of minus-strand HCV RNA. We spec-
ulate that the difference is due to the ratio of NS5B to template
used in our respective reaction mixtures. Piccininni et al. used
6.4-fold more enzyme than template RNA, while our reaction
mixtures had an equal or higher molar ratio of enzyme to
template. The multimeric product in the presence of NS3,
observed in the study by Piccininni et al., is inconsistent with de
novo RNA synthesis during HCV RNA replication. The pri-
mary mode of RNA synthesis during HCV replication in vivo
is initiated by a de novo mechanism. Despite the differences,
neither study observed that NS3FL or NS3H could increase de
novo RNA synthesis (Fig. 9) (43). In fact, both studies showed
that in the presence of 0.5 mM ATP or below, NS3 actually
decreased RNA synthesis by NS5B, possibly due to the NTPase
activity of NS3 decreasing the NTP concentration needed for
efficient RNA synthesis or the RNA-binding activity of NS3
that competes for the RNA template with NS5B.
In summary, the NS3 helicase activity is differentially mod-
ulated by the presence of the NS3 protease domain as well as










the viral RNA polymerase. Perhaps NS3 initially functions as a
protease responsible for viral polyprotein processing. Once
recruited into the HCV replication complex containing NS5B,
NS3 switches to serving as the helicase/NTPase that is required
for HCV RNA replication.
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